17-Apr-2026
MetLife Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited
Business Wire (Tue, 14-Apr 5:24 PM ET)
Bank of America Securities Sticks to Its Buy Rating for Metlife (MET)
TipRanks (Tue, 14-Apr 7:23 AM ET)
MetLife Investment Management Originates $26 Billion in Private Fixed Income Transactions in 2025
Business Wire (Thu, 9-Apr 8:30 AM ET)
MetLife to Announce First Quarter 2026 Results
Business Wire (Wed, 8-Apr 4:15 PM ET)
Cost Pressures Are Reshaping Today's Small and Mid-Sized Business Workforce
Business Wire (Tue, 7-Apr 9:00 AM ET)
MetLife Investment Management Names Andrea Drasites Head of Real Estate and Agricultural Finance
Business Wire (Thu, 2-Apr 4:30 PM ET)
AM Best Affirms Credit Ratings of MetLife, Inc. and Its Life/Health Subsidiaries
Business Wire (Wed, 1-Apr 5:20 PM ET)
Business Wire (Wed, 1-Apr 9:15 AM ET)
MetLife Names Jordan Canter Head of Federal Government Affairs and Regulatory Policy
Business Wire (Mon, 23-Mar 4:15 PM ET)
MetLife Study Finds AI Acceleration Is Creating New Concerns in Today's Workplace
Business Wire (Mon, 16-Mar 9:00 AM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of April 17, 2026, MET stock price climbed to $78.08 with 4,240,103 million shares trading.
MET has a beta of 1.05, meaning it tends to be more sensitive to market movements. MET has a correlation of 0.39 to the broad based SPY ETF.
MET has a market cap of $50.91 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $24 billion in Revenue and $2.49 earnings per share. This fell short of revenue expectation by $-7 billion and exceeded earnings estimates by $.14.
In the last 3 years, MET traded as high as $89.05 and as low as $48.95.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has underperformed the market in the last year with a return of +10.8%, while the SPY ETF gained +36.3%. In the last 3 month period, MET fell short of the market, returning +2.4%, while SPY returned +2.9%. However, in the most recent 2 weeks MET has outperformed the stock market by returning +10.4%, while SPY returned +8.3%.
MET support price is $75.66 and resistance is $78.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.